The key enzymatic activity of Novozym® 539 is provided by a serine endo-protease. It hydrolyzes internal peptide bonds. In diagnostics, that makes it highly suitable for lysis processes, as these need an efficient breakdown of viral cell walls.
A broad potential application range
Novozym® 539 has the potential to be used in a broad range of viral diagnostic applications. These include influenza, HIV and COVID-19.
A recombinant product
This is a recombinant product manufactured by microbial fermentation.
Novozym® 539 is an intermediate nucleus-free product. It can be upgraded to your required product specifications.
Activity: 35 KNPU-S/g.